ClinicalTrials.gov
ClinicalTrials.gov Menu

Study of the Effects of Oral AT1001 (Migalastat Hydrochloride) in Patients With Fabry Disease

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00925301
Recruitment Status : Completed
First Posted : June 22, 2009
Last Update Posted : May 2, 2016
Sponsor:
Information provided by (Responsible Party):
Amicus Therapeutics

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : July 2012
  Actual Study Completion Date : January 2014
  Certification/Extension First Submitted : September 25, 2013
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):